InMed Pharmaceuticals, Inc. (INM)

1.36 +0.03 (+2.26%) USD  |  NASDAQ  |  Oct 09, 16:00
1.37 +0.01 (+0.74%) After-Hours: 20:00
More

InMed Pharmaceuticals EPS Estimates for Current Quarter

EPS Estimates for Current Quarter Chart

View EPS Estimates for Current Quarter for INM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Estimates for Current Quarter Data

View and export this data back to 2022. Start Trial.
Date Value
May 13, 2022 --

Earnings Per Share Estimates Definition

This is the earnings consensus estimate for a given period of time, according to analysts polled by Standard & Poor's.

Read full definition.

EPS Estimates for Current Quarter Range, Past 5 Years

View EPS Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Estimates for Current Quarter Benchmarks

View EPS Estimates for Current Quarter Benchmarks
Start Trial
NervGen Pharma Corp. Upgrade
Milestone Pharmaceuticals, Inc. Upgrade
Clearmind Medicine, Inc. --
Lexaria Bioscience Corp. --
Target Group, Inc. (Canada) --

EPS Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade